Lead sponsor
HealthPartners Institute
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
1
Ongoing
84
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Not applicable
1
Trials by status
By invitation
1
Completed
1
Terminated
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseAlzheimer's diseasePh 2Terminated49
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.Alzheimer's diseasePh 2Completed12